Telemetry Investments’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21,695	Closed	-$491K	–	127
2019 Q1	$491K	Buy	+21,695	New	+$479K	0.98%	53
2018 Q3	–	Sell	-42,000	Closed	-$1.15M	–	171
2018 Q2	$1.15M	Sell	42,000 -20,960	-33%	-$558K	1.37%	35
2018 Q1	$1.41M	Buy	62,960 +2,624	+4%	+$62.5K	1.54%	37
2017 Q4	$1.27M	Buy	60,336 +19,336	+47%	+$442K	1.61%	39
2017 Q3	$1.02M	Sell	41,000 -19,000	-32%	-$418K	1.05%	44
2017 Q2	$1.16M	Buy	60,000 +16,000	+36%	+$290K	1.3%	38
2017 Q1	$812K	Buy	44,000 +6,000	+16%	+$117K	0.89%	41
2016 Q4	$719K	Buy	38,000 +3,734	+11%	+$76.4K	0.96%	43
2016 Q3	$767K	Sell	34,266 -35,734	-51%	-$680K	0.88%	37
2016 Q2	$1.25M	Sell	70,000 -94,153	-57%	-$1.52M	1.35%	30
2016 Q1	$2.24M	Sell	164,153 -15,847	-9%	-$240K	2.01%	26
2015 Q4	$3.47M	Buy	180,000 +32,000	+22%	+$639K	2.21%	21
2015 Q3	$3M	Sell	148,000 -2,500	-2%	-$74.1K	1.66%	23
2015 Q2	$4.99M	Buy	150,500 +70,900	+89%	+$1.94M	3.16%	12
2015 Q1	$1.91M	Buy	79,600 +61,100	+330%	+$932K	1.43%	26
2014 Q4	$226K	Buy	+18,500	New	+$191K	0.16%	144